|
|
Volumn 23, Issue 2, 2002, Pages 69-75
|
|
Parkinson's disease primer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIPARKINSON AGENT;
LEVODOPA;
ALPHA TOCOPHEROL;
AMANTADINE;
BROMOCRIPTINE MESILATE;
CATECHOL METHYLTRANSFERASE INHIBITOR;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
DOPAMINE RECEPTOR STIMULATING AGENT;
MONOAMINE OXIDASE INHIBITOR;
PERGOLIDE MESILATE;
PRAMIPEXOLE;
ROPINIROLE;
SELEGILINE;
AGE DISTRIBUTION;
AGED;
DISEASE COURSE;
FEMALE;
GERIATRIC NURSING;
HUMAN;
INCIDENCE;
LONG TERM CARE;
MALE;
METHODOLOGY;
MIDDLE AGED;
NURSING;
ONSET AGE;
PARKINSON DISEASE;
PATIENT EDUCATION;
PROGNOSIS;
REVIEW;
RISK FACTOR;
SEX RATIO;
ADULT;
AGE;
ARTICLE;
BODY POSTURE;
BRADYKINESIA;
CLINICAL PROTOCOL;
DEGENERATIVE DISEASE;
DIAGNOSTIC PROCEDURE;
LIVER DISEASE;
MEDICAL LITERATURE;
MOTOR DYSFUNCTION;
MUSCLE RIGIDITY;
PALLIDOTOMY;
PATHOPHYSIOLOGY;
PHYSICAL DISABILITY;
REST;
SYMPTOM;
TREMOR;
AGE DISTRIBUTION;
AGE OF ONSET;
AGED;
ANTIPARKINSON AGENTS;
DISEASE PROGRESSION;
FEMALE;
GERIATRIC NURSING;
HUMANS;
INCIDENCE;
LEVODOPA;
LONG-TERM CARE;
MALE;
MIDDLE AGED;
PARKINSON DISEASE;
PATIENT EDUCATION;
PROGNOSIS;
RISK FACTORS;
SEX DISTRIBUTION;
|
|
EID: 0036245363
PISSN: 01974572
EISSN: None
Source Type: Journal
DOI: 10.1067/mgn.2002.123789 Document Type: Article |
|
Times cited : (6)
|
|
References (10)
|
